Meeting News

Posted: December 2018 The IASLC Latin America Conference on Lung Cancer in August featured a new awards presentation. The awards, sponsored by the IASLC Latin America Group (LATAM) were, in the words of LATAM Chair Luis E. Raez, MD, “for people who have not only moved forward the mission and vision of the IASLC globally…

Posted: December 2018 The National Cancer Institute (NCI) held a Post-Treatment Surveillance Workshop at the Shady Grove Campus this past March. In addition to lung cancer, the workshop focused on prostate cancer, breast cancer, colon cancer and testicular cancer. The lung cancer breakout session was co-chaired by Dr. Shakun Malik (NCI) and Dr. Geoff Oxnard…

By Kara Nyberg, PhD Posted: October 2018 The Presidential Symposium at the IASLC World Conference on Lung Cancer 2018 (WCLC) showcased the top five scientific abstracts highlighting progress in detecting and treating different forms of lung cancer and mesothelioma. These presentations featured four positive clinical trials that advance current treatment standards and one negative clinical…

The conference’s program is stacked with science and education for scientists, clinicians, and advocates alike. By Leah K. Lawrence Posted: August 2018 The IASLC 19th World Conference on Lung Cancer (WCLC), the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, will take place this year from September 23 to 26 in Toronto,…

Figure. Prevalance of Water Pipe Usage Is Virtually at Epidemic Proportion in Parts of the Middle East Sources: Vardavas C, Filippidis F, Agaku I. http://tobaccocontrol.bmj.com. Accessed April 11, 2018. McKelvey KL, Wilcox ML, Madhivanan P, et al. Eur J Public Health. 2013;23(5):862-867. Florida Department of Health; 2012 Florida Youth Tobacco Survey. tobaccoatlas.org. Accessed April 11,…

Highlights from the IASLC 18th Lung Cancer Targeted Therapies Meeting keynote address. By Suresh S. Ramalingam, MD Posted: June 2018 EGFR-targeted therapy has entered a new phase as the result of several important advances in recent years. It is now well established that EGFR tyrosine kinase inhibitors (TKIs) are the preferred standard of care for…

By Roy S. Herbst, MD, PhD The National Cancer Institute’s (NCI’s) Lung Cancer Specialized Programs of Research Excellence (SPORE) and their affiliates met June 21-22, 2017, to discuss current trends in translational lung cancer research, plan collaborations, and design new projects. The event was hosted by Yale Cancer Center, the Yale SPORE in Lung Cancer…

The Heine Hansen Award recipient is IASLC Lung Cancer News Associate Editor Fabrice Barlesi, MD. His lecture will be “The Power of Multiple H.” “I’m unbelievably grateful to the ESMO and to the IASLC for this prestigious award, which honors not only me but all of the French teams that are diligently working in the…

By C.A.I.R.O Journal Club Executive Board Posted: April 2018 In early February, the Critical Appraisal Initiative for Research in Oncology (C.A.I.R.O) Journal Club celebrated its fourth anniversary by hosting a Lung Cancer 360 Forum in the Bibliotheca Alexandrina. The Forum was a 2-day interactive educational event that gathered 205 senior and early-career oncology physicians and…

By Chairs Suresh Ramalingam, MD, Paul Bunn, MD, PhD, Leora Horn, MD, MSc, and Roy Herbst, MD, PhD Posted: February 2018 Lung cancer research has reached an exciting point with the availability of a plethora of therapeutic strategies that have resulted in improved outcomes for patients. Recent advances include novel targeted therapies based on genomic…